Form D Explorer

Source evidence

Embold Therapeutics, Inc. · 0002109643-26-000003

D/A filed July 24, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
REDWOOD CITY
street1
2682 EATON AVE
zipCode
94062
entityName
Embold Therapeutics, Inc.
entityType
Corporation
stateOrCountry
CA
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold2470587number2470587/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount4975000number4975000/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count7number7/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: e0bc4c0c336af4c2e8447946d11cd2bfd3492ab699dbec9573564c6785efb4ce. This proves extraction identity, not the accuracy of the filer's claims.